All In Biotech

Drug Trial Radar · NCT07828860

Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa

A Phase 1b, Open-label Study Evaluating the Safety and Efficacy of Oral Soquelitinib in Adults With Moderate-to-Severe Hidradenitis Suppurativa

Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

25

Planned (sponsor's estimate)

Start

Sep 17, 2026

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Corvus Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Sep 18, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Safety and Efficacy of Soquelitinib in Adults with Hidradenitis Suppurativa

Conditions

  • Hidradenitis Suppurativa (HS)

Interventions

  • SoquelitinibDrug

    Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse events, changes in laboratory values, vital signs, and ECGsTime frame: up to 30 days after last intervention administration

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Site 9

    West Lafayette, Indiana · Not yet recruiting

  • Clinical Site 1

    Bowling Green, Kentucky · Recruiting

  • Clinical Site 2

    Owensboro, Kentucky · Recruiting

  • Clinical Site 3

    Boston, Massachusetts · Not yet recruiting

  • Clinical Site 5

    New York, New York · Recruiting

  • Clinical Site 4

    The Bronx, New York · Recruiting

  • Clinical Site 11

    Fargo, North Dakota · Recruiting

  • Clinical Site 10

    Mayfield Heights, Ohio · Recruiting

  • Clinical Site 6

    Camp Hill, Pennsylvania · Recruiting

  • Clinical Site 8

    Philadelphia, Pennsylvania · Recruiting

  • Clinical Site 7

    Nashville, Tennessee · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.